Jiangsu Bioperfectus Technologies Co., Ltd.

Vector-Borne Diseases are human illnesses caused by parasites, viruses and bacteria that are transmitted by vectors. Every year there are more than 700,000 deaths from Vector-Borne Diseases. The burden of these diseases is highest in tropical and subtropical areas, and they disproportionately affect the poorest populations. SHANGHAI, CHINA, March 21, 2023Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as BioPerfectus) is pleased to launch the following 6 new Real Time PCR Kits independently developed by BioPerfectus. BioPerfectus provides Vector-Borne Diseases Total Diagnostic Solutions from sample pre-processing to PCR amplification analysis for our partners to rapid response to a global health emergency. Vector-Borne Disease is a kind of infectious disease with arthropods as the transmission vector, which is transmitted to animals and human hosts through bites, mainly including mosquito-borne, tick-borne, mite-borne, lice-borne and flea-borne infectious diseases. Almost everyone has been bitten by bite.Examples of vector-borne diseases include Dengue fever,West Nile Virus, Lyme disease, and malaria. Some Vector-Borne Diseases, like Malaria, have been around for thousands of years. Others, like Tick-Borne Diseases, have been outbroken recently. Past outbreaks also indicate that preparedness is the key to infectious diseases. The capacity to recover, prepare for, and respond to outbreaks is very important. In this way, an earlier window for diagnosis is of great importance. Pioneering the field of molecular diagnostics, BioPerfectus consistently pursues excellence, embraces innovation, and remains dedicated to addressing health challenges faced by humanity in pursuit of a healthier future. Reference [1] https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases [2] https://www.cdc.gov/ncezid/dvbd/index.html [3] http://publichealth.lacounty.gov/acd/vector.htm

BioPerfectus is committed to supporting the development of public health and has established strong cooperative relationships with governmental health departments and NGOs worldwide to respond jointly to global or regional public health emergencies. Whenever an epidemic outbreak occurs, BioPerfectus provides robust support to our partners to deal with local emergencies. We are pleased to share our efforts in public health in Ecuador, where we have worked closely with the laboratories of the Ecuadorian Ministry of Health to combat the monkeypox outbreak and the COVID-19 pandemic, flu, and other infectious diseasesworldwideby providing BioPerfectus diagnostic solutions. Our Nucleic Acid Extraction System, Real-Time PCR System, and Multiple Assays have played a crucial role in the prompt and accurate detection and diagnosis of infectious diseases.The professionals from the Ministry of Health's laboratories highly value our diagnostic products and technical support. In particular, the high-throughput and automation capabilities of the SMPE-960, developed by BioPerfectus, can extract nucleic acids from 1-96 samples in three independently operating modules simultaneously. This has significantly reduced the turnaround time for test results, allowing for prompt and effective public health interventions. In Ecuador, vector-borne infections, including Dengue, Chikungunya, Yellow Fever, and Zika, are common, and BioPerfectus is always ready to respond to these infectious diseases with timely and accurate detection. We offer a complete set of diagnostic solutions for vector-borne virus detection based on both the Immuno-chromatographic platform and the Multiplex real-time PCR platform, satisfying the detection demands of different infectious procedures. Most vector-borne infections currently have no known treatment or vaccine. Therefore, early diagnosis and monitoring are critical for controlling these infectious diseases and improving treatment outcomes.

Gastrointestinal infections are among the most common infectious diseases worldwide, being exceeded only by respiratory tract infections. Although often considered a benign disease, acute gastroenteritis remains a major cause of morbidity and mortality in children around the world. According to the World Health Organization (WHO) report, there are over 1.7 billion cases of diarrheal disease worldwide every year. Furthermore, diarrheal diseases are the second leading cause of death in children under the age of five years. SHANGHAI, CHINA, March 16, 2023Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as BioPerfectus) is proud to launch following 10 new Real Time PCR Kits independently developed by BioPerfectus. When combined with our extraction solution and PCR system, we could provide a Total PCR Solution for the detection of gastrointestinal (GI) pathogens. Gastrointestinal infections are caused by a variety of bacterial, viral, and parasitic pathogens. These infections are mostly transmitted in poor hygienic conditions and by consuming contaminated food or water. Infections can also be transmitted from person to person by direct contact or through fomites. The most common symptom is diarrhea, which is usually a self-limiting disease, and most healthy individuals recover within a few days. The important causative agents of bacterial gastroenteritis and diarrhea are Campylobacter, Salmonella,Shigella, Plesiomonas,Vibrio, Yersinia enterocolitica, Clostridioides difficile(formerlyClostridium difficile), and pathogenic strains of Escherichia coli. Important causative agents of viral gastroenteritis are Adenovirus, Rotavirus, Astrovirus, and Norovirus. Dedicated to providing laboratories with comprehensive tests of GI Infections, BioPerfectus provides Gastrointestinal Infectious Diseases Diagnostic Solutionfrom sample pre-processing to PCR amplification analysis. Pioneering in molecular diagnostics, BioPerfectus is always devoted to pursuing high quality, keeps innovating, and committing to solving health problems faced by humankind for a healthier future. Reference: [1] Y. Zboromyrska and J. Vila, Advanced PCR-based molecular diagnosis of gastrointestinal infections: challenges and opportunities, Expert Review of Molecular Diagnostics, vol. 16, no. 6, pp. 631640, 2016 [2] Global, regional, and national causes of child mortality in 2008: a systematic analysis https://read.qxmd.com/read/20466419/global-regional-and-national-causes-of-child-mortality-in-2008-a-systematic-analysis [3] Diarrhoeal Disease, Key Facts, World Health Orgaization Website, Geneva, Switzerland, 2017. [4] N. M. Thielman and R. L. Guerrant, Acute infectious diarrhea, New England Journal of Medicine, vol. 350, no. 1, pp. 3847, 2004. [5] C. Stockmann, A. T. Pavia, B. Graham et al., Detection of 23 gastrointestinal pathogens among children who present with diarrhea, Journal of the Pediatric Infectious Diseases Society, vol. 6, no. 3, pp. 231238, 2017.